Quarterly Report

Aprea Therapeutics, Inc. Filed 2022-05-16 Acc 0001558370-22-008955

Documents 1

2022-08-12 10-Q Quarterly Report
2022-05-19 4 Director bought 50,000 shares at $0.71 ($35,500)
2022-05-19 4 Chairman & CEO bought 37,500 shares at $0.64 ($24,124)
2022-05-17 8-K Material agreement · Acquisition or sale completed · Delisting notice · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
2022-05-16 10-Q Quarterly Report
2022-05-16 8-K Results of operations · Regulation FD disclosure
2021-11-08 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading apre-20220331x10q.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…